ANIP Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2024-04-05 | 2021 | Christopher K. Mutz Senior Vice President, Head of Rare Disease | 338,462 | 0 | 508,060 | 247,482 | 9,231 | 1,605,932 |
| 2024-04-05 | 2022 | Ori Gutwerg Senior Vice President, Generics | 429,217 | 0 | 739,041 | 194,670 | 0 | 1,362,928 |
| 2024-04-05 | 2023 | Ori Gutwerg Senior Vice President, Generics | 445,254 | 0 | 1,046,532 | 449,904 | 0 | 1,941,690 |
| 2024-04-05 | 2023 | Chad Ga ssert Senior Vice President, Corporate Development and Strategy | 429,223 | 0 | 1,046,532 | 413,133 | 7,355 | 1,896,243 |
| 2024-04-05 | 2021 | Stephen P. Carey Senior Vice President and Chief Financial Officer | 491,319 | 0 | 1,743,585 | 594,000 | 21,650 | 2,850,554 |
| 2024-04-05 | 2022 | Stephen P. Carey Senior Vice President and Chief Financial Officer | 505,859 | 0 | 1,288,585 | 229,432 | 15,708 | 2,039,584 |
| 2024-04-05 | 2022 | Nikhil Lalwani President and Chief Executive Officer | 736,812 | 0 | 3,806,102 | 556,973 | 12,200 | 5,112,087 |
| 2024-04-05 | 2021 | Nikhil Lalwani President and Chief Executive Officer | 715,347 | 0 | 4,369,205 | 1,442,000 | 14,508 | 6,541,060 |
| 2024-04-05 | 2023 | Stephen P. Carey Senior Vice President and Chief Financial Officer | 509,857 | 0 | 1,465,142 | 584,289 | 16,800 | 2,576,088 |
| 2024-04-05 | 2021 | Ori Gutwerg Senior Vice President, Generics | 355,385 | 134,000 | 406,441 | 221,359 | 0 | 1,519,337 |
| 2024-04-05 | 2023 | Nikhil Lalwani President and Chief Executive Officer | 764,341 | 0 | 5,756,142 | 1,544,670 | 13,200 | 8,078,353 |
| 2024-04-05 | 2023 | Christopher K. Mutz Senior Vice President, Head of Rare Disease | 424,050 | 0 | 1,046,532 | 428,480 | 15,389 | 1,914,451 |
| 2024-04-05 | 2022 | Christopher K. Mutz Senior Vice President, Head of Rare Disease | 408,772 | 0 | 739,041 | 144,200 | 12,200 | 1,304,213 |
| 2023-04-11 | 2021 | Nikhil Lalwani President and Chief Executive Officer | 715,347 | 1,442,000 | 4,369,205 | 0 | 14,508 | 6,541,060 |
| 2023-04-11 | 2020 | Nikhil Lalwani President and Chief Executive Officer | 199,231 | 210,000 | 826,732 | 0 | 0 | 3,715,036 |
| 2023-04-11 | 2020 | James G. Marken Senior Vice President, Operations and Product Development | 426,267 | 276,300 | 1,158,911 | 0 | 13,057 | 1,874,535 |
| 2023-04-11 | 2022 | Stephen P. Carey Senior Vice President and Chief Financial Officer | 505,859 | 229,432 | 1,288,585 | 0 | 15,708 | 2,039,584 |
| 2023-04-11 | 2021 | Stephen P. Carey Senior Vice President and Chief Financial Officer | 491,319 | 594,000 | 1,743,585 | 0 | 21,650 | 2,850,554 |
| 2023-04-11 | 2020 | Stephen P. Carey Senior Vice President and Chief Financial Officer | 474,271 | 388,792 | 1,877,400 | 0 | 14,114 | 2,754,577 |
| 2023-04-11 | 2022 | James G. Marken Senior Vice President, Operations and Product Development | 454,767 | 206,258 | 758,269 | 0 | 12,200 | 1,431,494 |
| 2023-04-11 | 2021 | James G. Marken Senior Vice President, Operations and Product Development | 440,001 | 255,875 | 1,025,632 | 0 | 13,145 | 1,734,653 |
| 2023-04-11 | 2022 | Ori Gutwerg Senior Vice President, Generics | 429,217 | 194,670 | 739,041 | 0 | 0 | 1,362,929 |
| 2023-04-11 | 2021 | Ori Gutwerg Senior Vice President, Generics | 355,385 | 355,359 | 406,441 | 0 | 0 | 1,519,337 |
| 2023-04-11 | 2022 | Nikhil Lalwani President and Chief Executive Officer | 736,812 | 556,973 | 3,806,102 | 0 | 12,200 | 5,112,087 |
| 2022-03-25 | 2019 | James G. Marken Senior Vice President, Operations and Product Development | 410,637 | 185,400 | 454,639 | 0 | 12,548 | 1,398,766 |
| 2022-03-25 | 2020 | James G. Marken Senior Vice President, Operations and Product Development | 426,267 | 276,300 | 1,158,911 | 0 | 13,057 | 1,874,535 |
| 2022-03-25 | 2021 | James G. Marken Senior Vice President, Operations and Product Development | 440,001 | 255,875 | 1,025,632 | 0 | 13,145 | 1,734,653 |
| 2022-03-25 | 2020 | Nikhil Lalwani President and Chief Executive Officer | 199,231 | 210,000 | 826,732 | 0 | 0 | 3,715,036 |
| 2022-03-25 | 2019 | Stephen P. Carey Senior Vice President, Finance and Chief Financial Officer | 456,877 | 252,120 | 826,622 | 0 | 10,681 | 2,156,392 |
| 2022-03-25 | 2021 | Nikhil Lalwani President and Chief Executive Officer | 715,347 | 1,442,000 | 4,369,205 | 0 | 14,508 | 6,541,060 |
| 2022-03-25 | 2021 | Stephen P. Carey Senior Vice President, Finance and Chief Financial Officer | 491,319 | 594,000 | 1,743,585 | 0 | 21,650 | 2,850,554 |
| 2022-03-25 | 2020 | Stephen P. Carey Senior Vice President, Finance and Chief Financial Officer | 474,271 | 388,792 | 1,877,400 | 0 | 14,114 | 2,754,577 |
| 2022-03-25 | 2021 | Christopher K. Mutz Head of Rare Disease | 338,462 | 247,482 | 508,060 | 0 | 9,231 | 1,605,932 |
| 2022-03-25 | 2021 | Ori Gutwerg Senior Vice President, Generics | 355,385 | 355,359 | 406,441 | 0 | 0 | 1,519,337 |
| 2021-04-29 | 2019 | Robert W. Schrepfer Former Senior Vice President, New Business Development | 456,877 | 252,120 | 826,622 | 0 | 15,264 | 2,160,975 |
| 2021-04-29 | 2020 | Nikhil Lalwani | 199,231 | 210,000 | 826,732 | 0 | 0 | 3,715,036 |
| 2021-04-29 | 2020 | Stephen P. Carey Senior Vice President, Finance and Chief Financial Officer | 474,271 | 388,792 | 1,877,400 | 0 | 14,114 | 2,754,577 |
| 2021-04-29 | 2019 | Stephen P. Carey Senior Vice President, Finance and Chief Financial Officer | 456,877 | 252,120 | 826,622 | 0 | 10,681 | 2,156,392 |
| 2021-04-29 | 2018 | Stephen P. Carey Senior Vice President, Finance and Chief Financial Officer | 431,157 | 240,300 | 456,480 | 0 | 9,469 | 1,438,750 |
| 2021-04-29 | 2020 | James G. Marken Senior Vice President, Operations and Product | 426,267 | 276,300 | 1,158,911 | 0 | 13,057 | 1,874,535 |
| 2021-04-29 | 2019 | James G. Marken Senior Vice President, Operations and Product | 410,637 | 185,400 | 454,639 | 0 | 12,548 | 1,398,766 |
| 2021-04-29 | 2018 | James G. Marken Senior Vice President, Operations and Product | 387,695 | 192,000 | 251,064 | 0 | 12,463 | 1,009,589 |
| 2021-04-29 | 2020 | Robert W. Schrepfer Former Senior Vice President, New Business Development | 474,273 | 288,792 | 1,877,400 | 0 | 18,498 | 2,658,963 |
| 2021-04-29 | 2018 | Robert W. Schrepfer Former Senior Vice President, New Business Development | 431,159 | 240,300 | 456,480 | 0 | 14,873 | 1,444,156 |
| 2021-04-29 | 2020 | Patrick D. Walsh | 282,760 | 0 | 679,308 | 0 | 145 | 962,213 |
| 2021-04-29 | 2020 | Arthur S. Przybyl Former President and Chief Executive Officer | 332,847 | 0 | 0 | 0 | 524,967 | 857,814 |
| 2021-04-29 | 2019 | Arthur S. Przybyl Former President and Chief Executive Officer | 776,767 | 703,350 | 2,475,019 | 0 | 33,831 | 5,815,760 |
| 2021-04-29 | 2018 | Arthur S. Przybyl Former President and Chief Executive Officer | 726,925 | 675,000 | 1,660,446 | 0 | 30,634 | 4,197,933 |
| 2020-04-23 | 2019 | Stephen P. Carey Vice President, Finance and Chief Financial Officer | 456,877 | 0 | 826,622 | 252,120 | 10,681 | 2,156,392 |
| 2020-04-23 | 2018 | Stephen P. Carey Vice President, Finance and Chief Financial Officer | 431,157 | 0 | 456,480 | 240,300 | 9,469 | 1,438,750 |
| 2020-04-23 | 2017 | Robert W. Schrepfer Senior Vice President, New Business Development and Specialty Sales | 385,504 | 0 | 328,004 | 180,000 | 10,497 | 1,245,325 |
| 2020-04-23 | 2018 | Robert W. Schrepfer Senior Vice President, New Business Development and Specialty Sales | 431,159 | 0 | 456,480 | 240,300 | 14,873 | 1,444,156 |
| 2020-04-23 | 2019 | Robert W. Schrepfer Senior Vice President, New Business Development and Specialty Sales | 456,877 | 0 | 826,622 | 252,120 | 15,264 | 2,160,975 |
| 2020-04-23 | 2017 | James G. Marken Senior Vice President, Operations and Product Development | 353,342 | 0 | 179,474 | 144,000 | 11,919 | 875,495 |
| 2020-04-23 | 2018 | James G. Marken Senior Vice President, Operations and Product Development | 387,695 | 0 | 251,064 | 192,000 | 12,463 | 1,009,589 |
| 2020-04-23 | 2019 | James G. Marken Senior Vice President, Operations and Product Development | 410,637 | 0 | 454,639 | 185,400 | 12,548 | 1,398,766 |
| 2020-04-23 | 2017 | Stephen P. Carey Vice President, Finance and Chief Financial Officer | 389,233 | 0 | 328,004 | 180,000 | 8,000 | 1,246,557 |
| 2020-04-23 | 2019 | Arthur S. Przybyl President, Chief Executive Officer and Director | 776,767 | 0 | 2,475,019 | 703,350 | 33,831 | 5,815,760 |
| 2020-04-23 | 2018 | Arthur S. Przybyl President, Chief Executive Officer and Director | 726,925 | 0 | 1,660,446 | 675,000 | 30,634 | 4,197,933 |
| 2020-04-23 | 2017 | Arthur S. Przybyl President, Chief Executive Officer and Director | 647,270 | 0 | 1,175,863 | 506,250 | 27,309 | 3,580,292 |
| 2019-04-04 | 2016 | James G. Marken Senior Vice President, Operations and Product Development | 315,067 | 46,751 | 76,106 | 117,339 | 11,894 | 642,307 |
| 2019-04-04 | 2018 | Robert W. Schrepfer Senior Vice President, New Business Development and Specialty Sales | 431,159 | 0 | 456,480 | 240,300 | 14,873 | 1,444,156 |
| 2019-04-04 | 2017 | Robert W. Schrepfer Senior Vice President, New Business Development and Specialty Sales | 385,504 | 0 | 328,004 | 180,000 | 10,497 | 1,245,325 |
| 2019-04-04 | 2017 | James G. Marken Senior Vice President, Operations and Product Development | 353,342 | 0 | 179,474 | 144,000 | 11,919 | 875,495 |
| 2019-04-04 | 2016 | Robert W. Schrepfer Senior Vice President, New Business Development and Specialty Sales | 325,317 | 0 | 192,803 | 138,460 | 11,948 | 858,908 |
| 2019-04-04 | 2018 | James G. Marken Senior Vice President, Operations and Product Development | 387,695 | 0 | 251,064 | 192,000 | 12,463 | 1,009,589 |
| 2019-04-04 | 2018 | Arthur S. Przybyl President, Chief Executive Officer and Director | 726,925 | 0 | 1,660,446 | 675,000 | 30,634 | 4,197,933 |
| 2019-04-04 | 2016 | Stephen P. Carey Vice President, Finance and Chief Financial Officer | 229,848 | 0 | 0 | 96,012 | 0 | 1,472,360 |
| 2019-04-04 | 2017 | Stephen P. Carey Vice President, Finance and Chief Financial Officer | 389,233 | 0 | 328,004 | 180,000 | 8,000 | 1,246,557 |
| 2019-04-04 | 2018 | Stephen P. Carey Vice President, Finance and Chief Financial Officer | 431,157 | 0 | 456,480 | 240,300 | 9,469 | 1,438,750 |
| 2019-04-04 | 2016 | Arthur S. Przybyl President, Chief Executive Officer and Director | 572,000 | 57,200 | 761,063 | 343,200 | 29,100 | 2,514,063 |
| 2019-04-04 | 2017 | Arthur S. Przybyl President, Chief Executive Officer and Director | 647,270 | 0 | 1,175,863 | 506,250 | 27,309 | 3,580,292 |
| 2018-04-06 | 2017 | Stephen P. Carey Vice President, Finance and Chief Financial Officer | 389,233 | 0 | 328,004 | 180,000 | 8,000 | 1,246,557 |
| 2018-04-06 | 2017 | Arthur S. Przybyl President, Chief Executive Officer and Director | 647,270 | 0 | 1,175,863 | 506,250 | 27,309 | 3,580,292 |
| 2018-04-06 | 2016 | Arthur S. Przybyl President, Chief Executive Officer and Director | 572,000 | 57,200 | 761,063 | 343,200 | 29,100 | 2,514,063 |
| 2018-04-06 | 2015 | Arthur S. Przybyl President, Chief Executive Officer and Director | 568,331 | 0 | 1,030,650 | 343,200 | 10,000 | 2,950,581 |
| 2018-04-06 | 2016 | Stephen P. Carey Vice President, Finance and Chief Financial Officer | 229,848 | 0 | 0 | 96,012 | 0 | 1,472,360 |
| 2018-04-06 | 2017 | James G. Marken Senior Vice President, Operations and Product Development | 353,342 | 0 | 179,474 | 144,000 | 11,919 | 875,495 |
| 2018-04-06 | 2016 | James G. Marken Senior Vice President, Operations and Product Development | 315,067 | 46,751 | 76,106 | 117,339 | 11,894 | 642,307 |
| 2018-04-06 | 2015 | James G. Marken Senior Vice President, Operations and Product Development | 293,647 | 0 | 103,065 | 87,450 | 0 | 584,002 |
| 2018-04-06 | 2017 | Robert Schrepfer Senior Vice President, New Business Development and Specialty Sales | 385,504 | 0 | 328,004 | 180,000 | 10,497 | 1,245,325 |
| 2018-04-06 | 2016 | Robert Schrepfer Senior Vice President, New Business Development and Specialty Sales | 325,317 | 0 | 192,803 | 138,460 | 11,948 | 858,908 |
| 2018-04-06 | 2015 | Robert Schrepfer Senior Vice President, New Business Development and Specialty Sales | 300,262 | 0 | 206,130 | 120,400 | 0 | 826,472 |
| 2017-04-06 | 2014 | James G. Marken Senior Vice President, Operations and Product Development | 259,455 | 0 | 97,713 | 119,250 | 0 | 592,183 |
| 2017-04-06 | 2016 | Robert Schrepfer Senior Vice President, New Business Development and Specialty Sales | 325,317 | 0 | 192,803 | 138,460 | 11,948 | 858,908 |
| 2017-04-06 | 2015 | Robert Schrepfer Senior Vice President, New Business Development and Specialty Sales | 300,262 | 0 | 206,130 | 120,400 | 0 | 826,472 |
| 2017-04-06 | 2014 | Robert Schrepfer Senior Vice President, New Business Development and Specialty Sales | 259,159 | 0 | 148,050 | 159,000 | 0 | 1,123,059 |
| 2017-04-06 | 2016 | Arthur S. Przybyl President, Chief Executive Officer and Director | 572,000 | 57,200 | 761,063 | 343,200 | 29,100 | 2,514,063 |
| 2017-04-06 | 2015 | Arthur S. Przybyl President, Chief Executive Officer and Director | 568,331 | 0 | 1,030,650 | 343,200 | 10,000 | 2,950,581 |
| 2017-04-06 | 2014 | Arthur S. Przybyl President, Chief Executive Officer and Director | 461,452 | 0 | 379,008 | 447,300 | 10,000 | 1,751,915 |
| 2017-04-06 | 2016 | Stephen P. Carey Vice President, Finance and Chief Financial Officer | 229,848 | 0 | 0 | 96,012 | 0 | 1,472,360 |
| 2017-04-06 | 2016 | Charlotte C. Arnold Vice President, Finance and Chief Financial Officer | 140,133 | 0 | 170,478 | 0 | 1,396,548 | 1,867,479 |
| 2017-04-06 | 2015 | Charlotte C. Arnold Vice President, Finance and Chief Financial Officer | 368,831 | 0 | 288,582 | 148,000 | 0 | 1,071,653 |
| 2017-04-06 | 2014 | Charlotte C. Arnold Vice President, Finance and Chief Financial Officer | 303,080 | 0 | 177,660 | 195,000 | 0 | 889,460 |
| 2017-04-06 | 2016 | James G. Marken Senior Vice President, Operations and Product Development | 315,067 | 46,751 | 76,106 | 117,339 | 11,894 | 642,307 |
| 2017-04-06 | 2015 | James G. Marken Senior Vice President, Operations and Product Development | 293,647 | 0 | 103,065 | 87,450 | 0 | 584,002 |
| 2016-04-14 | 2015 | James G. Marken Vice President, Operations | 293,647 | 0 | 103,065 | 87,450 | 0 | 584,002 |
| 2016-04-14 | 2013 | James G. Marken Vice President, Operations | 131,433 | 0 | 530,994 | 73,805 | 0 | 1,454,507 |
| 2016-04-14 | 2015 | Robert Schrepfer Vice President, New Business Development and Contract Manufacturing | 300,262 | 0 | 206,130 | 120,400 | 0 | 826,472 |
| 2016-04-14 | 2013 | Robert Schrepfer Vice President, New Business Development and Contract Manufacturing | 91,404 | 0 | 0 | 98,000 | 0 | 1,304,573 |
| 2016-04-14 | 2013 | Arthur S. Przybyl President, Chief Executive Officer and Director | 200,543 | 200,000 | 2,399,115 | 187,688 | 5,343 | 5,319,920 |
| 2016-04-14 | 2015 | Charlotte C. Arnold Vice President, Finance and Chief Financial Officer | 368,831 | 0 | 288,582 | 148,000 | 0 | 1,071,653 |
| 2016-04-14 | 2014 | Robert Schrepfer Vice President, New Business Development and Contract Manufacturing | 259,159 | 0 | 148,050 | 159,000 | 0 | 1,123,059 |
| 2016-04-14 | 2014 | Charlotte C. Arnold Vice President, Finance and Chief Financial Officer | 303,080 | 0 | 177,660 | 195,000 | 0 | 889,460 |
| 2016-04-14 | 2013 | Charlotte C. Arnold Vice President, Finance and Chief Financial Officer | 133,561 | 100,000 | 726,203 | 100,000 | 0 | 2,136,357 |
| 2016-04-14 | 2014 | James G. Marken Vice President, Operations | 259,455 | 0 | 97,713 | 119,250 | 0 | 592,183 |
| 2016-04-14 | 2015 | Arthur S. Przybyl President, Chief Executive Officer and Director | 568,331 | 0 | 1,030,650 | 343,200 | 10,000 | 2,950,581 |
| 2016-04-14 | 2014 | Arthur S. Przybyl President, Chief Executive Officer and Director | 461,452 | 0 | 379,008 | 447,300 | 10,000 | 1,751,915 |
| 2015-04-24 | 2014 | Charlotte C. Arnold Vice President, Finance and Chief Financial Officer | 303,080 | 0 | 177,660 | 195,000 | 0 | 889,460 |
| 2015-04-24 | 2013 | Arthur S. Przybyl President, Chief Executive Officer and Director | 200,543 | 200,000 | 2,399,115 | 187,688 | 5,343 | 5,319,920 |
| 2015-04-24 | 2014 | Arthur S. Przybyl President, Chief Executive Officer and Director | 461,452 | 0 | 379,008 | 447,300 | 10,000 | 1,751,915 |
| 2015-04-24 | 2013 | Robert Schrepfer Vice President, New Business Development and Contract Manufacturing | 91,404 | 0 | 0 | 98,000 | 0 | 1,304,573 |
| 2015-04-24 | 2014 | Robert Schrepfer Vice President, New Business Development and Contract Manufacturing | 259,159 | 0 | 148,050 | 159,000 | 0 | 1,123,059 |
| 2015-04-24 | 2013 | Charlotte C. Arnold Vice President, Finance and Chief Financial Officer | 133,561 | 100,000 | 726,203 | 100,000 | 0 | 2,136,357 |
| 2014-04-11 | 2013 | James G. Marken Vice President, Operations | 131,433 | 0 | 530,994 | 73,805 | 0 | 736,232 |
| 2014-04-11 | 2013 | Charlotte C. Arnold Vice President and Chief Financial Officer | 133,561 | 100,000 | 627,286 | 100,000 | 0 | 960,547 |
| 2014-04-11 | 2013 | Robert Schrepfer Vice President, New Business Development and Contract Manufacturing | 91,404 | 0 | 0 | 98,000 | 0 | 189,404 |
| 2014-04-11 | 2013 | Arthur S. Przybyl President, Chief Executive Officer and Director | 200,543 | 200,000 | 2,072,006 | 187,688 | 5,343 | 2,665,580 |
| 2014-04-11 | 2012 | Phillip B. Donenberg Former Senior Vice President of Finance, Chief Financial Officer and Secretary | 308,000 | 0 | 0 | 100,000 | 28,113 | 585,738 |
| 2014-04-11 | 2013 | Phillip B. Donenberg Former Senior Vice President of Finance, Chief Financial Officer and Secretary | 172,360 | 0 | 0 | 0 | 793,709 | 966,069 |
| 2014-04-11 | 2012 | Stephen M. Simes Former Vice Chairman, President and Chief Executive Officer | 496,700 | 0 | 0 | 200,000 | 31,749 | 1,148,448 |
| 2014-04-11 | 2013 | Stephen M. Simes Former Vice Chairman, President and Chief Executive Officer | 382,634 | 0 | 0 | 0 | 1,521,812 | 1,904,446 |
| 2014-04-11 | 2013 | Robert J. Jamnick Vice President, Quality and Product Development | 112,551 | 0 | 502,596 | 63,202 | 0 | 678,349 |
| 2012-04-09 | 2010 | Phillip B. Donenberg Senior Vice President of Finance, Chief Financial Officer and Secretary | 285,552 | 112,000 | 0 | 0 | 28,663 | 530,215 |
| 2012-04-09 | 2011 | Phillip B. Donenberg Senior Vice President of Finance, Chief Financial Officer and Secretary | 308,000 | 0 | 0 | 122,357 | 27,368 | 746,625 |
| 2012-04-09 | 2010 | Michael C. Snabes, M.D., Ph.D. Senior Vice President of Medical Affairs | 374,487 | 109,500 | 0 | 0 | 18,200 | 528,187 |
| 2012-04-09 | 2011 | Michael C. Snabes, M.D., Ph.D. Senior Vice President of Medical Affairs | 376,000 | 0 | 0 | 98,700 | 18,200 | 621,300 |
| 2012-04-09 | 2009 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 417,640 | 275,000 | 0 | 0 | 37,162 | 1,038,802 |
| 2012-04-09 | 2011 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 496,700 | 0 | 0 | 302,490 | 38,739 | 1,533,429 |
| 2012-04-09 | 2010 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 486,231 | 270,900 | 0 | 0 | 36,248 | 949,379 |
| 2012-04-09 | 2009 | Phillip B. Donenberg Senior Vice President of Finance, Chief Financial Officer and Secretary | 232,140 | 175,000 | 0 | 0 | 2,150 | 557,397 |
| 2011-04-11 | 2010 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 486,231 | 270,900 | 0 | 0 | 36,248 | 949,379 |
| 2011-04-11 | 2008 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 417,640 | 0 | 0 | 0 | 30,879 | 697,519 |
| 2011-04-11 | 2009 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 417,640 | 275,000 | 0 | 0 | 37,162 | 1,038,802 |
| 2011-04-11 | 2010 | Michael C. Snabes, M.D., Ph.D. | 374,487 | 109,500 | 0 | 0 | 18,200 | 528,187 |
| 2011-04-11 | 2010 | Phillip B. Donenberg Senior Vice President of Finance, Chief Financial Officer and Secretary | 285,552 | 112,000 | 0 | 0 | 28,663 | 530,215 |
| 2011-04-11 | 2009 | Phillip B. Donenberg Senior Vice President of Finance, Chief Financial Officer and Secretary | 232,140 | 175,000 | 0 | 0 | 21,507 | 557,397 |
| 2011-04-11 | 2008 | Phillip B. Donenberg Senior Vice President of Finance, Chief Financial Officer and Secretary | 232,140 | 0 | 0 | 0 | 20,123 | 401,663 |
| 2010-04-29 | 2008 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 417,640 | 0 | 0 | 0 | 30,879 | 697,519 |
| 2010-04-29 | 2007 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 219,000 | 87,600 | 0 | 0 | 19,099 | 438,699 |
| 2010-04-29 | 2008 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 232,140 | 0 | 0 | 0 | 20,123 | 401,663 |
| 2010-04-29 | 2009 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 232,140 | 175,000 | 0 | 0 | 21,507 | 557,233 |
| 2010-04-29 | 2007 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 394,000 | 256,100 | 0 | 0 | 41,859 | 1,256,959 |
| 2010-04-29 | 2009 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 417,640 | 275,000 | 0 | 0 | 37,162 | 1,038,407 |
| 2009-04-27 | 2006 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 374,400 | 140,400 | 0 | 0 | 40,336 | 641,166 |
| 2009-04-27 | 2008 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 417,640 | 0 | 0 | 0 | 30,879 | 719,852 |
| 2009-04-27 | 2006 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 208,572 | 41,714 | 0 | 0 | 14,700 | 392,608 |
| 2009-04-27 | 2007 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 219,000 | 87,600 | 0 | 0 | 19,109 | 510,860 |
| 2009-04-27 | 2008 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 232,140 | 0 | 0 | 0 | 20,123 | 426,368 |
| 2009-04-27 | 2007 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 394,000 | 256,100 | 0 | 0 | 41,859 | 880,292 |
| 2008-04-29 | 2006 | Phillip B. Donenberg Chief Financial Officer, | 208,572 | 41,714 | 0 | 0 | 14,700 | 392,608 |
| 2008-04-29 | 2007 | Stephen M. Simes Vice Chairman, President | 394,000 | 256,100 | 0 | 0 | 41,859 | 880,292 |
| 2008-04-29 | 2006 | Stephen M. Simes Vice Chairman, President | 374,400 | 140,400 | 0 | 0 | 40,336 | 641,166 |
| 2008-04-29 | 2007 | Phillip B. Donenberg Chief Financial Officer, | 219,000 | 87,600 | 0 | 0 | 19,109 | 510,860 |
| 2007-04-26 | 2006 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 208,572 | 41,714 | 0 | 0 | 14,700 | 392,608 |
| 2007-04-26 | 2006 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 374,400 | 140,400 | 0 | 0 | 40,336 | 641,166 |
| 2006-04-28 | 2003 | Leah M. Lehman, Ph.D. Former Vice President, Product Development | 199,500 | 59,850 | 0 | 0 | 0 | 259,350 |
| 2006-04-28 | 2005 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 374,400 | 0 | 0 | 0 | 33,927 | 408,327 |
| 2006-04-28 | 2004 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 360,000 | 120,000 | 0 | 0 | 0 | 480,000 |
| 2006-04-28 | 2003 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 323,400 | 161,700 | 0 | 0 | 34,088 | 519,188 |
| 2006-04-28 | 2005 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 198,640 | 150,000 | 0 | 0 | 0 | 348,640 |
| 2006-04-28 | 2004 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 191,000 | 51,000 | 0 | 0 | 27,239 | 269,239 |
| 2006-04-28 | 2003 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 166,215 | 49,865 | 0 | 0 | 0 | 216,080 |
| 2006-04-28 | 2005 | Steven J. Bell, Ph.D. Vice President, Research and Pre-Clinical Development | 166,400 | 35,000 | 0 | 0 | 14,200 | 215,600 |
| 2006-04-28 | 2004 | Steven J. Bell, Ph.D. Vice President, Research and Pre-Clinical Development | 160,000 | 32,000 | 0 | 0 | 0 | 192,000 |
| 2006-04-28 | 2003 | Steven J. Bell, Ph.D. Vice President, Research and Pre-Clinical Development | 140,000 | 42,000 | 0 | 0 | 14,807 | 196,807 |
| 2006-04-28 | 2005 | Leah M. Lehman, Ph.D. Former Vice President, Product Development | 249,600 | 0 | 0 | 0 | 0 | 249,600 |
| 2006-04-28 | 2004 | Leah M. Lehman, Ph.D. Former Vice President, Product Development | 240,000 | 40,000 | 0 | 0 | 14,347 | 294,347 |
| 2005-04-29 | 2004 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 340,000 | 120,000 | 0 | 0 | 34,088 | 494,088 |
| 2005-04-29 | 2003 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 323,400 | 0 | 0 | 0 | 0 | 323,400 |
| 2005-04-29 | 2002 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 308,000 | 161,700 | 0 | 0 | 27,239 | 496,939 |
| 2005-04-29 | 2004 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 191,000 | 92,400 | 0 | 0 | 0 | 283,400 |
| 2005-04-29 | 2003 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 166,215 | 0 | 0 | 0 | 44,585 | 210,800 |
| 2005-04-29 | 2002 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 158,300 | 51,000 | 0 | 0 | 0 | 209,300 |
| 2005-04-29 | 2004 | Leah M. Lehman, Ph.D. Vice President, Product Development | 240,000 | 0 | 0 | 0 | 14,807 | 254,807 |
| 2005-04-29 | 2003 | Leah M. Lehman, Ph.D. Vice President, Product Development | 199,500 | 49,865 | 0 | 0 | 0 | 249,365 |
| 2005-04-29 | 2002 | Leah M. Lehman, Ph.D. Vice President, Product Development | 190,000 | 28,494 | 0 | 0 | 14,347 | 232,841 |
| 2005-04-29 | 2004 | Steven J. Bell, Ph.D. Vice President, Research and Pre-Clinical Development | 160,000 | 0 | 0 | 0 | 0 | 160,000 |
| 2005-04-29 | 2003 | Steven J. Bell, Ph.D. Vice President, Research and Pre-Clinical Development | 140,000 | 80,000 | 0 | 0 | 13,759 | 233,759 |
| 2005-04-29 | 2002 | Steven J. Bell, Ph.D. Vice President, Research and Pre-Clinical Development | 120,000 | 0 | 0 | 0 | 0 | 120,000 |
| 2004-04-29 | 2003 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 323,400 | 161,700 | 0 | 0 | 27,239 | 512,339 |
| 2004-04-29 | 2001 | Steven J. Bell, Ph.D. Vice President, Research and Pre-Clinical Development | 102,000 | 30,000 | 0 | 0 | 11,250 | 143,250 |
| 2004-04-29 | 2003 | Leah M. Lehman, Ph.D. Vice President, Clinical and Regulatory Affairs | 199,500 | 59,850 | 0 | 0 | 13,200 | 272,550 |
| 2004-04-29 | 2001 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 150,000 | 45,000 | 0 | 0 | 13,592 | 208,592 |
| 2004-04-29 | 2002 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 158,300 | 28,494 | 0 | 0 | 13,759 | 200,553 |
| 2004-04-29 | 2003 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 166,215 | 49,865 | 0 | 0 | 14,347 | 230,427 |
| 2004-04-29 | 2001 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 291,500 | 131,175 | 0 | 0 | 18,388 | 441,063 |
| 2004-04-29 | 2002 | Steven J. Bell, Ph.D. Vice President, Research and Pre-Clinical Development | 120,000 | 21,600 | 0 | 0 | 11,500 | 153,100 |
| 2004-04-29 | 2003 | Steven J. Bell, Ph.D. Vice President, Research and Pre-Clinical Development | 140,000 | 42,000 | 0 | 0 | 12,000 | 194,000 |
| 2004-04-29 | 2001 | Leah M. Lehman, Ph.D. Vice President, Clinical and Regulatory Affairs | 180,000 | 54,000 | 0 | 0 | 12,450 | 246,450 |
| 2004-04-29 | 2002 | Leah M. Lehman, Ph.D. Vice President, Clinical and Regulatory Affairs | 190,000 | 34,200 | 0 | 0 | 12,700 | 236,900 |
| 2004-04-29 | 2002 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 308,000 | 92,400 | 0 | 0 | 44,585 | 444,985 |
| 2003-04-28 | 2002 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 308,000 | 92,400 | 0 | 0 | 44,585 | 444,985 |
| 2003-04-28 | 2000 | Steven J. Bell, Ph.D. Vice President, Research and Pre-Clinical Development | 91,521 | 26,000 | 0 | 0 | 11,250 | 128,771 |
| 2003-04-28 | 2001 | Steven J. Bell, Ph.D. Vice President, Research and Pre-Clinical Development | 102,000 | 30,000 | 0 | 0 | 11,250 | 143,250 |
| 2003-04-28 | 2002 | Steven J. Bell, Ph.D. Vice President, Research and Pre-Clinical Development | 120,000 | 21,600 | 0 | 0 | 11,500 | 153,100 |
| 2003-04-28 | 2000 | Leah M. Lehman, Ph.D. Vice President, Clinical Development | 0 | 0 | 0 | 0 | 0 | 0 |
| 2003-04-28 | 2001 | Leah M. Lehman, Ph.D. Vice President, Clinical Development | 180,000 | 54,000 | 0 | 0 | 12,450 | 246,450 |
| 2003-04-28 | 2002 | Leah M. Lehman, Ph.D. Vice President, Clinical Development | 190,000 | 34,200 | 0 | 0 | 12,700 | 236,900 |
| 2003-04-28 | 2000 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 127,000 | 42,000 | 0 | 0 | 13,286 | 182,286 |
| 2003-04-28 | 2001 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 150,000 | 45,000 | 0 | 0 | 13,592 | 208,592 |
| 2003-04-28 | 2002 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 158,300 | 28,494 | 0 | 0 | 13,759 | 200,553 |
| 2003-04-28 | 2000 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 275,000 | 150,000 | 0 | 0 | 29,317 | 454,317 |
| 2003-04-28 | 2001 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 291,500 | 131,175 | 0 | 0 | 18,388 | 441,063 |
| 2002-04-29 | 2001 | Steven J. Bell, Ph.D. Vice President, Research and Pre-Clinical Development | 102,000 | 30,000 | 0 | 0 | 11,250 | 143,250 |
| 2002-04-29 | 2000 | Steven J. Bell, Ph.D. Vice President, Research and Pre-Clinical Development | 91,521 | 26,000 | 0 | 0 | 11,250 | 128,771 |
| 2002-04-29 | 2001 | John E. Lee Former Vice President, Commercial Development | 146,407 | 0 | 0 | 0 | 9,338 | 155,745 |
| 2002-04-29 | 1999 | Steven J. Bell, Ph.D. Vice President, Research and Pre-Clinical Development | 85,313 | 10,000 | 0 | 0 | 6,500 | 101,813 |
| 2002-04-29 | 2000 | John E. Lee Former Vice President, Commercial Development | 70,833 | 0 | 0 | 0 | 81,470 | 152,303 |
| 2002-04-29 | 1999 | John E. Lee Former Vice President, Commercial Development | 0 | 0 | 0 | 0 | 0 | 0 |
| 2002-04-29 | 2001 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 291,500 | 131,175 | 0 | 0 | 18,388 | 441,063 |
| 2002-04-29 | 2000 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 275,000 | 150,000 | 0 | 0 | 29,317 | 454,317 |
| 2002-04-29 | 1999 | Stephen M. Simes Vice Chairman, President and Chief Executive Officer | 248,917 | 125,000 | 0 | 0 | 22,965 | 396,882 |
| 2002-04-29 | 2001 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 150,000 | 45,000 | 0 | 0 | 13,592 | 208,592 |
| 2002-04-29 | 2000 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 127,000 | 42,000 | 0 | 0 | 13,286 | 182,286 |
| 2002-04-29 | 1999 | Phillip B. Donenberg Chief Financial Officer, Treasurer and Secretary | 110,000 | 33,000 | 0 | 0 | 13,001 | 156,001 |
| 2002-04-29 | 2001 | Leah M. Lehman, Ph.D. Vice President, Clinical Development | 180,000 | 54,000 | 0 | 0 | 12,450 | 246,450 |
| 2002-04-29 | 2000 | Leah M. Lehman, Ph.D. Vice President, Clinical Development | 0 | 0 | 0 | 0 | 0 | 0 |
| 2002-04-29 | 1999 | Leah M. Lehman, Ph.D. Vice President, Clinical Development | 0 | 0 | 0 | 0 | 0 | 0 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
